User profiles for Bin Ju
Bin Ju南方科技大学副研究员 Verified email at mail.sustech.edu.cn Cited by 2327 |
[HTML][HTML] Human neutralizing antibodies elicited by SARS-CoV-2 infection
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) presents a global health emergency that is in urgent …
syndrome coronavirus 2 (SARS-CoV-2) presents a global health emergency that is in urgent …
[HTML][HTML] Clinical outcome of direct pulp capping with MTA or calcium hydroxide: a systematic review and meta-analysis
C Zhu, B Ju, R Ni - … journal of clinical and experimental medicine, 2015 - ncbi.nlm.nih.gov
Direct pulp capping is one of the most common dental practices in endodontic therapy. This
systematic review and meta-analysis aim to determine whether the effect of mineral trioxide …
systematic review and meta-analysis aim to determine whether the effect of mineral trioxide …
[PDF][PDF] Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge
during the global pandemic and may facilitate escape from current antibody therapies and …
during the global pandemic and may facilitate escape from current antibody therapies and …
[PDF][PDF] The architecture of inactivated SARS-CoV-2 with postfusion spikes revealed by cryo-EM and cryo-ET
…, L Mendonça, Y Yang, Y Gao, C Shen, J Liu, T Ni, B Ju… - Structure, 2020 - cell.com
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) resulted from the
outbreak of SARS-CoV-2 in December 2019. Currently, multiple efforts are being made to …
outbreak of SARS-CoV-2 in December 2019. Currently, multiple efforts are being made to …
[HTML][HTML] Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants
B Ju, Q Zhang, Z Wang, ZQ Aw, P Chen, B Zhou… - Nature …, 2023 - nature.com
The omicron variants of SARS-CoV-2 have substantial ability to escape infection- and
vaccine-elicited antibody immunity. Here, we investigated the extent of such escape in nine …
vaccine-elicited antibody immunity. Here, we investigated the extent of such escape in nine …
[HTML][HTML] Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
Neutralizing antibodies (nAbs) to SARS-CoV-2 hold powerful potentials for clinical
interventions against COVID-19 disease. However, their common genetic and biologic features …
interventions against COVID-19 disease. However, their common genetic and biologic features …
[HTML][HTML] Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Understanding the mechanism for antibody neutralization of SARS-CoV-2 is critical for the
development of effective therapeutics and vaccines. We recently isolated a large number of …
development of effective therapeutics and vaccines. We recently isolated a large number of …
[HTML][HTML] Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning
W Xu, NN Sun, HN Gao, ZY Chen, Y Yang, B Ju… - Scientific reports, 2021 - nature.com
COVID-19 is a newly emerging infectious disease, which is generally susceptible to human
beings and has caused huge losses to people's health. Acute respiratory distress syndrome (…
beings and has caused huge losses to people's health. Acute respiratory distress syndrome (…
[HTML][HTML] Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA. 4/5/2.75 subvariants in BA. 2 breakthrough infections
B Ju, Q Fan, M Wang, X Liao, H Guo, H Wang… - Nature …, 2022 - nature.com
With declining SARS-CoV-2-specific antibody titers and increasing numbers of spike mutations,
the ongoing emergence of Omicron subvariants causes serious challenges to current …
the ongoing emergence of Omicron subvariants causes serious challenges to current …
[PDF][PDF] Key gp120 glycans pose roadblocks to the rapid development of VRC01-class antibodies in an HIV-1-infected Chinese donor
VRC01-class antibodies neutralize diverse HIV-1 strains by targeting the conserved CD4-binding
site. Despite extensive investigations, crucial events in the early stage of VRC01 …
site. Despite extensive investigations, crucial events in the early stage of VRC01 …